Background Metformin is the gold standard insulin sensitizer, which is widely used to treat
insulin resistance in polycystic ovary syndrome (PCOS). However, metformin may induce …

ABSTRACT Introduction This Expert Opinion covers recent updates in the use of Inositol in
polycystic ovary syndrome (PCOS) and type II diabetes and gives support to researchers …

Myo-inositol, also known as inositol (cyclohexanehexol), is a cyclic carbohydrate with six
hydroxyl groups. 1 For a long time, it was considered a B vitamin (vitamin B8). However, it is …

Background: The aim of the present study is to investigate the effects produced by a
treatment with myo-Inositol (myo-Ins) in women presenting polycystic ovary syndrome …

Objective: This study was conducted to see the effects of berberine, metformin, and
myoinositol in women with polycystic ovary syndrome (PCOS). Materials and Methods …

Background and Objectives: The Quantum Menstrual Health Monitoring Study will measure
four key reproductive hormones in the urine (follicle-stimulating hormone, FSH; estrone-3 …

Abstract Objective Polycystic Ovary Syndrome is the most prevalent hormonal disorder in
females. Over the years, metformin (MET) has become the first-line choice of treatment; …

Background Although hormonal and metabolic dysfunction have been recognized as a
possible cause of polycystic ovarian syndrome (PCOS), the associations between …

OBJECTIVE: This meta-analysis aims to perform an updated meta-analysis to evaluate myo-
inositol (myo-ins) and the classical insulin sensitizer metformin in terms of efficacy and safety …

Metformin was found to decrease elevated levels of anterior pituitary hormones. Its impact
on lactotrope secretory function was absent in women with vitamin D insufficiency. This …